Your browser doesn't support javascript.
loading
Systematic review and meta-analysis of the diagnostic effectiveness of positron emission tomography-computed tomography versus magnetic resonance imaging in the post-treatment surveillance of head and neck squamous cell carcinoma.
Zhu, Y; McLaren, O; Hardman, J; Evans, J; Williams, R.
Afiliación
  • Zhu Y; Department of ENT, University Hospitals Plymouth NHS Trust, UK.
  • McLaren O; Department of ENT, University Hospitals Plymouth NHS Trust, UK.
  • Hardman J; Head and Neck Unit, The Royal Marsden NHS Foundation Trust, London, UK.
  • Evans J; Musculoskeletal Research Unit, University of Bristol, UK.
  • Williams R; Department of ENT, University Hospitals Plymouth NHS Trust, UK.
J Laryngol Otol ; 137(1): 22-30, 2023 Jan.
Article en En | MEDLINE | ID: mdl-35086577
OBJECTIVE: There is currently no consensus on the ideal protocol of imaging for post-treatment surveillance of head and neck squamous cell carcinoma. This study aimed to consolidate existing evidence on the diagnostic effectiveness of positron emission tomography-computed tomography versus magnetic resonance imaging. METHOD: Systematic electronic searches were conducted using Medline, Embase and Cochrane Library (updated February 2021) to identify studies directly comparing positron emission tomography-computed tomography and magnetic resonance imaging scans for detecting locoregional recurrence or residual disease for post-treatment surveillance. RESULTS: Searches identified 3164 unique records, with three studies included for meta-analysis, comprising 176 patients. The weighted pooled estimates of sensitivity and specificity for scans performed three to six months post-curative treatment were: positron emission tomography-computed tomography, 0.68 (95 per cent confidence interval, 0.49-0.84) and 0.89 (95 per cent confidence interval, 0.84-0.93); magnetic resonance imaging, 0.72 (95 per cent confidence interval, 0.54-0.88) and 0.85 (95 per cent confidence interval, 0.79-0.89), respectively. CONCLUSION: Existing studies do not provide evidence for superiority of either positron emission tomography-computed tomography or magnetic resonance imaging in detecting locoregional recurrence or residual disease following curative treatment of head and neck squamous cell carcinoma.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tomografía Computarizada por Tomografía de Emisión de Positrones / Neoplasias de Cabeza y Cuello Tipo de estudio: Diagnostic_studies / Screening_studies / Systematic_reviews Límite: Humans Idioma: En Revista: J Laryngol Otol Asunto de la revista: OTORRINOLARINGOLOGIA Año: 2023 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tomografía Computarizada por Tomografía de Emisión de Positrones / Neoplasias de Cabeza y Cuello Tipo de estudio: Diagnostic_studies / Screening_studies / Systematic_reviews Límite: Humans Idioma: En Revista: J Laryngol Otol Asunto de la revista: OTORRINOLARINGOLOGIA Año: 2023 Tipo del documento: Article Pais de publicación: Reino Unido